PRP for Eyebrow Hypotrichosis and Alopecia Areata
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if platelet-rich plasma (PRP), derived from a participant's own blood, can promote hair growth in individuals with thin eyebrows. Participants will receive either PRP or a saline solution in their eyebrows to compare effects. The trial will last nine months and assess the practicality of this approach. It suits individuals in the Chicago area with mild to moderate eyebrow thinning who are in good health. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group.
Will I have to stop taking my current medications?
If you are using medications that affect eyebrow hair growth, like minoxidil or bimatoprost, you can continue them if you've been on them for at least 12 months and agree to keep the same dose during the study. However, if you started these medications within 6 months of screening, you may not be eligible to participate.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research has shown that platelet-rich plasma (PRP) is generally safe for treating hair and eyebrow issues. Studies have found that PRP can cause mild side effects, such as pain, a burning sensation, scalp discomfort, and temporary redness. These effects are usually mild and resolve on their own. Importantly, these studies have found no evidence of serious problems from using PRP.
PRP has been used to treat alopecia areata, a type of hair loss, and has shown promise in promoting hair regrowth. While more research is needed to fully understand its effectiveness, current findings suggest that PRP is a safe option for those seeking to improve hair growth.12345Why do researchers think this study treatment might be promising?
Platelet-rich plasma (PRP) is unique because it uses a person's own blood components to potentially stimulate hair growth in conditions like eyebrow hypotrichosis and alopecia areata. Unlike traditional treatments, which often involve topical solutions or oral medications like corticosteroids and minoxidil, PRP involves injecting concentrated platelets directly into the skin. This delivery method allows PRP to directly target affected areas, potentially enhancing hair restoration. Researchers are excited because PRP may offer a more natural and potentially effective way to regenerate hair with fewer side effects compared to conventional therapies.
What evidence suggests that platelet-rich plasma might be an effective treatment for eyebrow hypotrichosis?
Research has shown that platelet-rich plasma (PRP), which participants in this trial may receive, can aid in hair regrowth. One study found that 52.8% of individuals with alopecia areata, a condition causing hair loss, experienced improvement after PRP treatment. This suggests that PRP may promote hair growth. Another study reported positive effects of PRP on male pattern hair loss without major side effects. Although limited information exists on PRP's effects on thinning eyebrows, these findings suggest it might be beneficial for similar conditions. Participants in this trial may also receive a placebo treatment with sterile saline for comparison.13467
Who Is on the Research Team?
Murad Alam
Principal Investigator
Northwestern University
Are You a Good Fit for This Trial?
This trial is for adults aged 18-85 in the Chicago area with mild to moderate eyebrow thinning who are healthy and can give informed consent. It's not for those with uncontrolled diseases affecting hair growth, recent use of certain hair growth drugs, significant blood disorders, genetic conditions impacting fibroblasts or collagen, pregnant/breastfeeding individuals, or those unable to follow the study protocol.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive intradermal injections of either autologous PRP or sterile saline to eyebrows, with three treatments performed 1 month apart
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Platelet-rich Plasma
- Saline
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor